Summary:
A randomized, double blind, placebo- and active-controlled, 4 week, multi-center, parallel group study assessing the analgesic effect, safety and tolerability of pf-06372865(oral medication) in subjects with chronic low back pain using naproxen as positive control.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Body mass index between 17.5 to 40 kg/m2 and a total body weight at least greater than 110lbs.
•
Chronic low back pain greater than 3 months requiring regular use of analgesic medication( greater than 4 days per week for the last month), such as nsaids, mild opiates, etc.
•
More inclusion/exclusion criteria apply
Qualified Participants May Receive:
All study related visits, tests, and medication will be provided to participants at no cost. In addition, reimbursement for study-related time and travel may be provided to participants who qualify. 8 visits. $50 per completed visit.